PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
115.4K views | +194 today
Follow

Hépatite C: une ONG va créer un traitement concurrent au blockbuster de Gilead, à prix cassé

From www.latribune.fr

En co-création avec Médecins sans frontières, l'ONG DNDI s'est associée
No comment yet.

Infograph: What new drugs will be approved by 2020?

From medcitynews.com

A new IMS report found that the 2015 late phase pipeline includes 2,320 novel products - and projects that more than 200 new drugs will be approved by 2020.
No comment yet.

Big Data: un atout pour l'industrie pharmaceutique | Alphalyr 

From www.alphalyr.fr

Le Big data est aussi une formidable opportunité pour les laboratoires pharmaceutiques sur le plan "business". L'analyse des données permet d'améliorer 
No comment yet.

Infographie : usage mobile des médecins en 2016

From buzz-esante.fr

Dans le cadre de l’Observatoire des usages numériques en santé en partenariat avec le CNOM, Vidal publie son 4ème baromètre sur l’usage mobile des médecins
No comment yet.

Debunking Digital Patient Recruitment Myths for Clinical Trials: Myth #1

From www.mdconnectinc.com

Many clinical trial recruiters don't do digital recruitment because they think their patients aren't online — it's time to set the record straight.
No comment yet.

IBM, Pfizer launch joint experiment to help measure Parkinson’s symptoms using IoT and analytics

From techcrunch.com

IBM, Pfizer launch joint experiment to help measure Parkinson’s symptoms using IoT and analytics
No comment yet.

Meeting the Multi-Channel Marketing Challenge

From www.pharmexec.com

The technology is ready, but it has never really been a technology issue. It’s always a cultural issue, and I don’t see how we can really change the model without first understanding what kind of companies we have, what we’re shooting for, and where the technology can help.
No comment yet.

Pharma Marketing Buzzwords: The Good, the Bad, & the Just Plain Useless!

From www.news.pharma-mkting.com

Lately, there's been a lot of "buzz" regarding the use of "buzzwords" at commercial pharma conferences focused on marketing and sales. Critics have suggested that buzzwords erode patient and healthcare professional trust in the pharmaceutical industry.

Even industry insiders question the use of buzzwords. "We on the commercial side of the business have an unhealthy obsession with 'buzzwords'," said Timothy White, Senior Director & Head of Global Customer Interaction Management at Lundbeck.

All the negative buzz about pharma buzzwords inspired the creation of the Pharma Marketing Buzzword Bingo Card (shown here) and the Pharma Marketing News "Pharma Buzzword Survey," which asked respondents to grade a list of buzzwords commonly heard at conferences and marketing meetings within pharmaceutical companies. This article summarizes the results of that survey.

Topics (partial list):

 

  • Massively Counter-Productive?
  • A Failure to Communicate?
  • Unhealthy Obsession?
  • The Patient Included Charter
  • Table: A Non-Definitive List of Pharma Marketing Buzzwords.
  • In Defense of Buzzwords
  • Pharma Buzzword Bingo
  • Grading Pharma's Favorite Buzzwords
  • Survey Results
  • Buzzword Blame Game


Download the full article (PDF file) here:
www.pharma-mkting.com/news/pmnews1404-article01.pdf

No comment yet.

Pfizer And IBM Launch Ambitious 'Internet Of Things' For Parkinson's Research

From www.forbes.com

Pfizer is betting big on the Internet of Things, or IoT, in medicine – that is, the connectivity of physical objects like medical devices to collect and exchange data – to boost Parkinson’s R&D and ultimately, to better inform care for patients.
To make this nebulous idea a reality, the pharmaceutical company is partnering with computer titan IBM to develop a system of sensors, mobile devices and machines that could deliver real-time, around-the-clock disease symptom monitoring of Parkinson’s patients to clinicians and researchers.

Pharma Guy's curator insight, April 7, 7:58 AM

Also read: "Another #Wearable Device for Parkinson's #Pharma Research. This One Backed by MJFF"; http://sco.lt/6K4ZfN 

Ipsen collabore avec Dassault Systèmes pour booster la recherche pharma au numérique

From www.usine-digitale.fr

Le laboratoire pharmaceutique Ipsen a conclu un accord de coopération avec Dassault Systèmes.

Objectif : s’appuyer sur les outils numériques de l’éditeur de logiciels de simulation et maquette 3D pour transformer sa R&D sur de nouveaux médicaments.
No comment yet.

Hausse du marché pharmaceutique mondial

From www.jim.fr

Le marché pharmaceutique mondial continue sa croissance avec une progression de 8,9% en 2015 à 1 069 milliards de dollars, selon une étude présentée parIMS Health.
No comment yet.

Darwinisme Digital ? Adapt or Die !

From www.carrementplus.net

Connaissez-vous le darwinisme digital ? Il s'agit d'une idéologie reprenant certaines idées de l'adaptation des espèces, à l'ère numérique. L'objectif n'est pas de reprendre mot pour mot les préceptes de Charles Darwin, mais bien de prendre en considération des concepts clés.
No comment yet.

Virtual Conferencing: A Roadmap for Pharma

From fr.slideshare.net

A pragmatic Roadmap for the pharmaceutical and medtech industries to digitize their conference and events channels. Presentation is a follow-up to an earler de…
No comment yet.

Patient engagement strategies in a digital environment: Life sciences companies respond to changing patient expectations

From dupress.com

In a shifting health care landscape, nontraditional players are trying to frame patient engagement strategies that are focused on providing patients solutions that are coordinated, convenient, customized, and accessible.
No comment yet.

#NETaccelerator : LE NET AU SERVICES DES NET ou Comment le digital contribue à améliorer la vie des patients atteints de tumeur neuroendocrines (NET)

From www.linkedin.com

Ironie de l’histoire alors qu’Apple vient d’annoncer le lancement de CareKit (synthèse de HealthKit et ResearchKit) le groupe Ipsen, en association a
No comment yet.

Apple's CareKit opens new door for pharma to develop apps, but will it walk through?

From www.fiercepharmamarketing.com

Apple just made pharma's move beyond the pill a little easier. With the announcement of CareKit last week, Apple promises easy-to-use software to create integrated iPhone apps that can more easily track and manage health conditions. However, the question is, will pharma take them up on the offer?
No comment yet.

Socialize Your Patient Engagement Strategy authors Letizia Affinito & John Mack

From www.routledge.com

Socialize Your Patient Engagement Strategy authors Letizia Affinito & John Mack talk to us about the concept of Patient Value, the risks associated with digital communication in the healthcare industry and tips on how to transform social media strategies for organizations.

No comment yet.

Retour sur la participation de Sanofi au Hackathon de Strasbourg

From labsante.sanofi.fr

Sanofi a tenu à participer une nouvelle fois à ce week-end dédié à l'innovation en santé pour les patients, au cœur de la medtech alsacienne.
No comment yet.

Note to pharma: Stop fishing social media one hook at a time. A trawl net works much better

From www.fiercepharmamarketing.com

Social listening has become a common tool for many pharma marketers. But it's not enough, says a new white paper co-authored by IMS Health and UCB Pharma.

UCB's Greg Cohen

Pharma typically uses social listening only for one-off projects to answer a specific question. But that kind of tactical thinking isn't broad enough to tap the bigger benefits of social listening, said Greg Cohen, associate director in global strategic marketing at UCB.

"Many of those companies think it's some sort of Big Brother-NSA kind of thing, listening in to all your conversations," he said in an interview. "But it's no different than a lot of other market research applications, except that it's so much more--it's a way for marketers to find out what patients are really saying and how they're saying it."

[Webinar] Inspection Readiness Considerations with AbbVieDATE: WEDNESDAY, APRIL 13 |  2PM ET / 11AM PT

Moving from paper-based to electronic processes not only requires a shift in technology but also a change in mindset. Hear AbbVie’s lessons learned from a mock inspection and other considerations for maintaining an inspection ready TMF. Reserve Your Spot Today!

Sign up for our FREE newsletter for more news like this sent to your inbox!

He and paper co-author Siva Nadarajah, IMS Health's general manager of social media, maintain that pharma companies that aren't using social listening strategically are squandering competitive advantages and the opportunity to do better-targeted--and therefore more efficient and effective--marketing.

Their white paper cites a Best Practices study that found while 85% of healthcare and pharma companies surveyed are engaged in some type of social listening, only one-third use it as a source of competitive intelligence.

 IMS Health's Siva Nadarajah

And for pharma still using the regulatory "excuse" of having to report adverse events they run across on social media, both authors agree the problem is highly overestimated. In a case of the fear being much larger than the reality, Nadarajah said, 2% or fewer of social media posts are accountable to adverse effects reporting.

They advise pharma companies to do continuous monitoring of social media, which not only results in current patient insights, but when advanced analytics are applied, can help predict future patient behavior.

The value of social listening is a theme IMS Health has been beating regularly over the past few years, but Nadarajah and Cohen said the paper was written now to continue pushing the message to pharma to act more strategically. IMS Health offers cloud-based social monitoring through its Nexxus Social platform.

"Rather than dismissing this dialogue as empty chatter or worrying about the implications of hearing something that might be more trouble than it is worth, industry needs to adopt practices from more consumer-oriented sectors and embrace social media intelligence on a continuous-listening basis," the authors wrote in the paper.

No comment yet.

Les médicaments les plus onéreux devront prouver leur intérêt

From www.lemonde.fr

Un décret fixe les règles de remboursement des molécules les plus chères prescrites à l’hôpital.
No comment yet.

Pourquoi la France va dégringoler à la 8ème place dans la pharma d’ici à 2020

From www.usinenouvelle.com

Le mouvement semble inéluctable. Depuis plusieurs années, notre marché pharmaceutique décroche. A tel point qu’en 2020,... Sujets liés Pharmacie / Biotechnologies, L'Usine de la Santé - Actualité de l'industrie
No comment yet.

How 3D printing will change the pharmaceutical world forever

From thenextweb.com

New possibilities in 3D printing may open up a whole new chapter of opportunities for pharmaceutical research and bio-technology applications. There are a
No comment yet.